Regional Analysis
Neutralizing Antibody Market Regional Insights
- North America: North America is the largest market for neutralizing antibodies, accounting for a market share of 41.8% in 2023. The region is home to some of the leading pharmaceutical companies, such as Genentech, BioLegend, and Thermo Fisher Scientific. These companies are investing heavily in the development of new neutralizing antibodies for the treatment of various diseases.
- Europe: Europe is the second largest market for neutralizing antibodies, accounting for a market share of 28.2% in 2023. The region has a strong presence of pharmaceutical companies such as Roche, Novartis, and Sanofi. These companies are also investing heavily in the development of new neutralizing antibodies.
- Asia Pacific: Asia Pacific is the fastest growing market for neutralizing antibodies, accounting for a market share of 22.0% in 2021. The region is home to a large and growing population, which is susceptible to a variety of infectious diseases. The rising prevalence of infectious diseases, coupled with the increasing investments in research and development, is driving the growth of the market in Asia Pacific.
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East & Africa: GCC Countries, Israel, South Africa, North Africa, and Central Africa and Rest of Middle East
|
U.S.: 
U.K. : 
India : 
